Comment
doi: 10.1016/j.jcjo.2016.11.019.
Epub 2017 Jan 5.
Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion
Affiliations
- PMID: 28237141
- DOI: 10.1016/j.jcjo.2016.11.019
Item in Clipboard
Comment
Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion
Can J Ophthalmol.
2017 Feb.
No abstract available
Comment in
-
Re: Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion.Can J Ophthalmol. 2017 Feb;52(1):137-138. doi: 10.1016/j.jcjo.2016.12.001. Can J Ophthalmol. 2017. PMID: 28237140 No abstract available.
Comment on
-
Effect of aflibercept on refractory macular edema associated with central retinal vein occlusion.Can J Ophthalmol. 2016 Oct;51(5):342-347. doi: 10.1016/j.jcjo.2016.02.001. Epub 2016 Sep 3. Can J Ophthalmol. 2016. PMID: 27769324
Similar articles
-
EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.Retina. 2018 Sep;38(9):1795-1800. doi: 10.1097/IAE.0000000000001782. Retina. 2018. PMID: 28767552 Clinical Trial.
-
The effect of switching ranibizumab to aflibercept in refractory cases of macular edema secondary to ischemic central vein occlusion.Klin Monbl Augenheilkd. 2015 Apr;232(4):552-5. doi: 10.1055/s-0035-1545783. Epub 2015 Apr 22. Klin Monbl Augenheilkd. 2015. PMID: 25902119
-
Re: Effect of Aflibercept on Refractory Macular Edema Associated with Central Retinal Vein Occlusion.Can J Ophthalmol. 2017 Feb;52(1):137-138. doi: 10.1016/j.jcjo.2016.12.001. Can J Ophthalmol. 2017. PMID: 28237140 No abstract available.
-
Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.Retina. 2014 Dec;34(12):2439-43. doi: 10.1097/IAE.0000000000000238. Retina. 2014. PMID: 24999721
-
Aflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion.Drugs Aging. 2017 May;34(5):393-400. doi: 10.1007/s40266-017-0458-6. Drugs Aging. 2017. PMID: 28365905 Review.
Cited by
-
Safety and long-term efficacy of repeated dexamethasone intravitreal implant for the treatment of cystoid macular edema secondary to retinal vein occlusion with and without a switch to anti-VEGF agents: a 3-year experience.Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2269-2270. doi: 10.1007/s00417-018-4094-6. Epub 2018 Aug 2. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 30069751 No abstract available.
-
Romanian ophthalmologists in the renowned ophthalmic journals worldwide.Rom J Ophthalmol. 2018 Oct-Dec;62(4):260-269. Rom J Ophthalmol. 2018. PMID: 30891521 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
